Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2024-07-08 Proxy Solicitation & In…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice regarding the dispatch of a Postal Ballot Notice for the appointment of a Non-Executive Director, Mr. Eric Mansion, at Sanofi India Limited. It includes the calendar of events for the postal ballot process, instructions for remote e-voting, and references to relevant sections of the Companies Act, 2013. The document is not a report itself but a formal announcement and notice to shareholders about the voting process and the proposed resolution. It does not contain financial statements, audit information, or management discussion. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), as it is material sent to shareholders to provide information and request votes for a meeting or resolution.
2024-07-08 English
Please find enclosed a copy of the Postal Ballot Notice together with the Explanatory Statement for your record. We have also enclosed the Calendar of Events for the Postal Ballot process ....
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice regarding the dispatch of a Postal Ballot Notice for the appointment of a Non-Executive Director, Mr. Eric Mansion, at Sanofi India Limited. It includes the calendar of events for the postal ballot process, instructions for remote e-voting, and references to relevant sections of the Companies Act, 2013. The document is not a report of voting results but rather the notice and explanatory statement sent to shareholders to solicit their votes electronically. It is a solicitation and information statement for shareholders to vote on a resolution, not the announcement of the results or a meeting presentation. Therefore, this document fits the category of Proxy Solicitation & Information Statement (PSI).
2024-07-08 English
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company has provided ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, provided by the Registrar and Share Transfer Agent (RTA) for the quarter ended 30th June 2024. It confirms the dematerialisation of securities and related compliance activities. The document is a formal certification letter addressed to stock exchanges and does not contain financial statements or detailed financial analysis. It is short (3113 characters) and serves as a regulatory compliance certificate rather than a financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and certification documents.
2024-07-08 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, provided by the Registrar and Share Transfer Agent (RTA) for the quarter ended 30th June 2024. It confirms the dematerialisation of securities and related compliance activities. The document is a formal certification letter addressed to stock exchanges and does not contain financial statements, management discussion, or detailed report content. It is primarily an attestation or confirmation letter related to regulatory compliance rather than a financial report or announcement of voting results. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a compliance certificate and does not qualify as an Interim Report or any other financial report type.
2024-07-08 English
Board Meeting — SANOFI INDIA LIMITED has informed the Exchange about Board Meeting to be held on 26-Jul-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the…
Regulatory Filings
2024-07-08 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notification dated 8th July 2024 from Sanofi India Limited addressed to stock exchanges about an upcoming Board of Directors meeting scheduled for 26th July 2024. The purpose of the meeting is to approve the unaudited financial statements for the quarter and half year ended 30th June 2024. It also mentions the closure of the trading window for insiders during this period. The document is short (1961 characters) and serves as an announcement of a future board meeting and related compliance information. It does not contain any financial statements, detailed financial data, or the actual report itself. Therefore, it is not an Interim/Quarterly Report (IR) or Annual Report (10-K). It is also not a certification or voting result. The document fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about a board meeting and upcoming financial results approval, without substantive financial data or report content.
2024-07-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.